Boston, MA USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Finding New Targets to Treat Vascular Damage

Christian-Rask-Madsen-websize.jpg

There are no established drugs to improve angiogenesis in diabetes. However, researchers at Joslin Diabetes Center now have identified a gene called CITED2 in a molecular pathway that may offer targets for drugs that treat these conditions by...
25-Aug-2016 2:05 PM EDT Add to Favorites

Umbilical Cells Shed Light on How Obesity May Pass From Mother to Child

Elvira-Isganaitis-MD-LabPhotoforPR.jpg

Researchers at Joslin Diabetes Center now have demonstrated that umbilical cells from children of obese or overweight mothers show impaired expression of key genes regulating cell energy and metabolism, compared to similar cells from babies of...
22-Aug-2016 3:05 PM EDT Add to Favorites

In Cells, Some Oxidants Are Needed

Keith-Blackwell-MD-PHD-Joslin-Diabetes-Center_2.jpg

But some studies are showing that these reactive oxygen species (ROS) molecules sometimes can aid in maintaining health—findings now boosted by a surprising discovery from Joslin Diabetes Center researchers.
18-Aug-2016 3:05 PM EDT Add to Favorites

Dr. Jennifer Sun, Investigator in the Section of Vascular Biology, Receives RPB Physician-Scientist Award from Research to Prevent Blindness

Jennifer_Sun_MD.jpg

Jennifer K. Sun, M.D., MPH, Investigator in the Section on Vascular Biology at Joslin Diabetes Center, an Ophthalmologist in Beetham Eye Institute (BEI) at Joslin Diabetes Center and Associate Professor at Harvard Medical School, has been granted an...
19-Jul-2016 3:05 PM EDT Add to Favorites

Finding New Clues to a Sugar Suspect in Birth Defects

loeken.jpg

Most pregnant women with well-controlled diabetes give birth to healthy children. But their babies run much higher risks of birth defects than babies born to women without diabetes, because very early in embryonic development, the babies are exposed...
22-Jun-2016 4:05 PM EDT Add to Favorites

Overweight and Obese Type 2 Patients Show Significant Improvements with Structured Nutrition Therapy According to New Study

Researchers at Joslin Diabetes Center have announced the results of a study that may change how nutrition therapy is delivered to overweight and obese patients with type 2 diabetes.
21-Jun-2016 11:05 AM EDT Add to Favorites

Joslin Diabetes Center Announces Extended Collaboration with Sanofi for the Development of Novel Treatments for Diabetes Complications

Joslin Diabetes Center, a research and clinical affiliate of Harvard Medical School, today announced a newly signed collaboration with Sanofi (EURONEXT: SAN and NYSE: SNY) which extends their ongoing collaboration in exploring novel targets for...
9-Jun-2016 9:05 AM EDT Add to Favorites

Dr. George King, Chief Scientific Officer at Joslin, to Receive the JDRF Mary Tyler Moore and S. Robert Levine Excellence in Clinical Research Award for Type 1 Research

George_King_sitting.jpg

George L. King, M.D., Chief Scientific Officer at Joslin Diabetes Center and Professor of Medicine at Harvard Medical School, has been selected to receive the 2016 JDRF Mary Tyler Moore and S. Robert Levine Excellence in Clinical Research Award.
2-Jun-2016 10:05 AM EDT Add to Favorites

Our Experts on Newswise

Dr. Lori Laffel, Chief of Pediatrics at Joslin Diabetes Center, Available to Comment on Type 1 Diabetes and Life Expectancy Studies

Laffel21.jpg

6-Jan-2015 11:00 AM EST

Back to School with Dr. Lori Laffel from Joslin Diabetes Center

laffel28.jpg

Lori Laffel, M.D., MPH, Chief of the Pediatric, Adolescent and Young Adult Section at Joslin Diabetes Center and Associate Professor of Pediatrics at Harvard Medical School, oversees the largest pediatric diabetes clinic in New England has over 25...
15-Aug-2014 8:00 AM EDT

Joslin Diabetes Center’s Cathy Carver Deciphers the ACA for People with Diabetes

Cathy-Carver.JPG

13-Nov-2013 1:00 PM EST

Expert Available: Bariatric Surgery for Diabetes

The International Diabetes Federation now recommends that surgery be considered as a treatment for obese patients with type 2 diabetes. Dr. Allison Goldfine, head of clinical research at Joslin Diabetes Center, is available for comment.
29-Mar-2011 9:00 AM EDT

Q&A: Howard Wolpert, M.D., and the Quest for an Artificial Pancreas

Howard_Wolpert_of_Joslin_Diabetes_Center.JPG

Emerging technologies such as continuous glucose monitoring (CGM) are helping people with type 1 diabetes manage their condition—what are the next steps? Howard Wolpert, M.D., of Joslin Diabetes Center discusses his current research and the global...
1-Oct-2010 1:00 PM EDT

Our YouTube Videos





Chat now!